A clinical trans-omics multidisciplinary study to understand the role of antiretroviral therapy in premature ageing of the immune system in HIV-infection
Description: Background: In the absence of cure or vaccine, long-term HIV infection, even with successful treatment, is associated with an enhanced onset of aging related complications on the people who are living with HIV (PLHIV).Aim: The aims of the present study are to use complimentary multidisciplinary expertise to unravel the physiological and molecular pathways that underline the pre-mature aging of the immune system (immune-aging) and potentially generate novel therapeutic approaches for age-related diseases on PLHIV.Method: In a bedside-to-bench and back approach, we will first identify the patient cohort, starting with the ideal randomized trial and working back to what is possible from the registry using the national HIV-registry, InfCareHIV which has longitudinal data since 1993. We will use both clinical and advanced laboratory parameters (92 inflamatory markers, miRNA, immune senesence marker) including the physiological measurement of age (i.e., Telomer length or Fraility) in a large number of patients. We will also perform multi-omics technologies like transcriptomics, proteomics, metabolomics, microbiome and conventional immunological assays in a sub-cell specific manner at a single cell resolution. Finally we will validate using mechanistic studies.Significance: This multidiciplinary study potentially identify a frame of reference for what might be required in clinical intervention strategies to delay the premature aging to improve the quality of life in PLHIV.
Funder: Vetenskapsrådet
Amount: SEK 24,910,000
Funding type: research
Funder scheme: Research environment
Start date: 2018-12-01
End date: 2023-11-30
Investigator: Ujjwal Neogi (lead)
Institution: Karolinska Institutet
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Funded outputs count: 52
Funder award ID: 2018-06156
OpenAlex ID: G3970695152
